We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS

Artificial Intelligence in Drug Discovery Market, By Therapeutic Space, By Application, By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

  • Published In : Aug 2023
  • Code : CMI6125
  • Pages :190
  • Formats :
      Excel and PDF
  • Industry : Healthcare IT

Leading Companies

Companies covered:

IBM Corporation (IBM Watson Health), Exscientia, GNS Healthcare, Alphabet, Inc. (DEEPMIND), Benevolent AI, Biosymetrics, Euretos, Berg LLC., Atomwise, Inc., Insitro, and among others.

Global Artificial Intelligence in Drug Discovery Market: Key Companies Insights

  • The global artificial intelligence in drug discovery market is highly competitive. This is attributed to the rise demand for advanced, technological advancement, strategic collaborations and launching new platforms in the market.
  • Some of the key players in the global Artificial Intelligence in Drug Discovery Market are IBM Corporation (IBM Watson Health), Exscientia, GNS Healthcare, Alphabet, Inc. (DEEPMIND), Benevolent AI, Biosymetrics, Euretos, Berg LLC., Atomwise, Inc., Insitro, and among others.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.